Literature DB >> 22370764

Enhanced oxidative stress in GH-transgenic rat and acromegaly in humans.

Hitoshi Nishizawa1, Anastasia-Evi Handayaningsih, Genzo Iguchi, Yoshitake Cho, Michiko Takahashi, Masaaki Yamamoto, Kentaro Suda, Kohei Kasahara, Fumihiko Hakuno, Keitaro Yamanouchi, Masugi Nishihara, Susumu Seino, Shin-Ichiro Takahashi, Yutaka Takahashi.   

Abstract

BACKGROUND: Excessive oxidative stress plays a causal role in various diseases such as diabetes, hypertension, atherosclerosis, and heart failure. Acromegaly is a pathological condition associated with excess growth hormone (GH) and insulin-like growth factor-I (IGF-I) and a high prevalence of diabetes, hypertension, atherosclerosis, and heart failure; resulting in premature death. We hypothesized that these conditions may be associated with increased oxidative stress. OBJECTIVE AND METHODS: We explored the oxidative stress levels in the serum and tissues of GH-transgenic rats as an animal model for acromegaly. We also measured the oxidative stress levels in the serum of patients with acromegaly and age-, sex-, and BMI-matched control subjects. We examined the effects of GH and IGF-I on reactive oxygen species (ROS) production in C2C12 myocytes.
RESULTS: The levels of an oxidative stress marker, serum thiobarbituric acid reactive substances (TBARS) were increased in the GH-transgenic rats. Further, tissue oxidative stress damage was enhanced in the cardiomyocytes and vascular smooth muscle cells in the aorta of the GH-transgenic rats. In addition, serum TBARS levels and 8-hydroxy-2-deoxyguanosine (8-OHdG) levels were increased in acromegaly in humans. IGF-I but not GH induced ROS production in C2C12 myocytes in vitro.
CONCLUSIONS: These data indicate that the increased levels of IGF-I are associated with enhanced oxidative stress in rats and humans. In addition, increased ROS may play an important role in the complications and premature death in acromegaly.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22370764     DOI: 10.1016/j.ghir.2012.02.001

Source DB:  PubMed          Journal:  Growth Horm IGF Res        ISSN: 1096-6374            Impact factor:   2.372


  10 in total

Review 1.  Oxidative stress and the ageing endocrine system.

Authors:  Giovanni Vitale; Stefano Salvioli; Claudio Franceschi
Journal:  Nat Rev Endocrinol       Date:  2013-02-26       Impact factor: 43.330

Review 2.  Peptide Hormone Regulation of DNA Damage Responses.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

3.  Serum paraoxonase level and paraoxonase polymorphism in patients with acromegaly.

Authors:  Dilek Arpaci; Sevim Karakas Celik; Murat Can; Esra Ermiş; Fatih Kuzu; Furuzan Kokturk; Ayse Ceylan Hamamcioglu; Ahmet Dursun; Taner Bayraktaroglu
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

4.  Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly.

Authors:  Cigdem Ozkan; Alev Eroglu Altinova; Ethem Turgay Cerit; Cagri Yayla; Asife Sahinarslan; Duygu Sahin; Aylin Sepici Dincel; Fusun Balos Toruner; Mujde Akturk; Metin Arslan
Journal:  Pituitary       Date:  2015-10       Impact factor: 4.107

5.  A novel ND1 mitochondrial DNA mutation is maternally inherited in growth hormone transgenesis in amago salmon (Oncorhynchus masou ishikawae).

Authors:  Tomohiko Sato; Naoko Goto-Inoue; Masaya Kimishima; Jike Toyoharu; Ryuhei Minei; Atsushi Ogura; Hiroyuki Nagoya; Tsukasa Mori
Journal:  Sci Rep       Date:  2022-04-25       Impact factor: 4.996

Review 6.  The Endothelium in Acromegaly.

Authors:  Pietro Maffei; Francesca Dassie; Alexandra Wennberg; Matteo Parolin; Roberto Vettor
Journal:  Front Endocrinol (Lausanne)       Date:  2019-07-24       Impact factor: 5.555

Review 7.  Acromegaly, inflammation and cardiovascular disease: a review.

Authors:  Thalijn L C Wolters; Mihai G Netea; Niels P Riksen; Adrianus R M M Hermus; Romana T Netea-Maier
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

8.  Ageing genetic signature of hypersomatotropism.

Authors:  Abdalla Elbialy
Journal:  Open Biol       Date:  2021-04-14       Impact factor: 6.411

9.  Accelerated Telomere Shortening in Acromegaly; IGF-I Induces Telomere Shortening and Cellular Senescence.

Authors:  Ryusaku Matsumoto; Hidenori Fukuoka; Genzo Iguchi; Yukiko Odake; Kenichi Yoshida; Hironori Bando; Kentaro Suda; Hitoshi Nishizawa; Michiko Takahashi; Shozo Yamada; Wataru Ogawa; Yutaka Takahashi
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

10.  A Zebrafish Acromegaly Model Elevates DNA Damage and Impairs DNA Repair Pathways.

Authors:  Abdalla Elbialy; Shuichi Asakawa; Shugo Watabe; Shigeharu Kinoshita
Journal:  Biology (Basel)       Date:  2018-10-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.